VA

Vaishali Arvindbhai Vasani

Director Additional Director DIN 02811414
DIN 02811414 First appointment Nov 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Vaishali Arvindbhai Vasani

Data last updated:

Vaishali Arvindbhai Vasani was an Additional Director at Vaishali Pharma Limited (2009). The company operates in Pharma.

DIN 02811414
Primary Designation Additional Director
Industry Pharma
First Appointment 07 Nov 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vaishali Pharma Limited L52310MH2008PLC181632
Additional Director07 Nov 20092008₹102 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vaishali Pharma Limited
Premium access

Shareholding and investment profile for Vaishali Arvindbhai Vasani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaishali Arvindbhai Vasani

Vaishali Arvindbhai Vasani was first appointed on 07 Nov 2009 as Additional Director at Vaishali Pharma Limited.

Vaishali Arvindbhai Vasani held 1 earlier board appointment: Vaishali Pharma Limited (Additional Director, 07 Nov 2009 to 14 Nov 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available